http://www.basilea.com/ Basilea News en Wed, 22 May 2013 09:19:56 +0200 Wed, 22 May 2013 09:19:56 +0200 Chameleon CMS webmaster@basila.com (Webmaster Webmaster) webmaster@basila.com (Webmaster Webmaster) http://www.basilea.com/News-and-Media/Basilea-reports-presentation-of-new-data-on-anti-infective-drug-candidates-addressing-drug-resistance/463 Mon, 29 Apr 2013 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-reports-presentation-of-new-data-on-anti-infective-drug-candidates-addressing-drug-resistance/463 http://www.basilea.com/News-and-Media/Resolutions-of-the-Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/461 Tue, 09 Apr 2013 17:13:53 +0200 http://www.basilea.com/News-and-Media/Resolutions-of-the-Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/461 http://www.basilea.com/News-and-Media/Basileas-Board-proposes-Martin-Nicklasson-to-succeed-Chairman-Werner-Henrich-and-recommends-to-shareholders-that-they-do-not-support-the-request-for-a-capital-distribution-at-this-time/459 Thu, 07 Mar 2013 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basileas-Board-proposes-Martin-Nicklasson-to-succeed-Chairman-Werner-Henrich-and-recommends-to-shareholders-that-they-do-not-support-the-request-for-a-capital-distribution-at-this-time/459 http://www.basilea.com/News-and-Media/Basilea-receives-request-to-place-repayment-of-CHF-48-million-from-capital-contribution-reserve-on-the-agenda-of-the-ordinary-general-meeting-of-shareholders/457 Fri, 22 Feb 2013 23:50:52 +0100 http://www.basilea.com/News-and-Media/Basilea-receives-request-to-place-repayment-of-CHF-48-million-from-capital-contribution-reserve-on-the-agenda-of-the-ordinary-general-meeting-of-shareholders/457 http://www.basilea.com/News-and-Media/Basilea-reports-2012-financials-with-a-solid-cash-position-and-significant-milestones-ahead/456 Thu, 07 Feb 2013 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-reports-2012-financials-with-a-solid-cash-position-and-significant-milestones-ahead/456 http://www.basilea.com/News-and-Media/Basilea-reports-recruitment-completion-of-phase-3-pivotal-study-of-isavuconazole-an-agent-for-the-potential-primary-treatment-of-invasive-and-life-threatening-fungal-infections/453 Fri, 14 Dec 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-reports-recruitment-completion-of-phase-3-pivotal-study-of-isavuconazole-an-agent-for-the-potential-primary-treatment-of-invasive-and-life-threatening-fungal-infections/453 http://www.basilea.com/News-and-Media/Basilea-appoints-Ronald-Scott-as-CEO-to-succeed-Anthony-Man-and-expands-management-team/451 Mon, 10 Dec 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-appoints-Ronald-Scott-as-CEO-to-succeed-Anthony-Man-and-expands-management-team/451 http://www.basilea.com/News-and-Media/Basilea-initiates-next-phase-1-multiple-ascending-dose-study-with-antibiotic-BAL30072-active-against-multidrug-resistant-Gram-negative-bacteria/450 Thu, 22 Nov 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basilea-initiates-next-phase-1-multiple-ascending-dose-study-with-antibiotic-BAL30072-active-against-multidrug-resistant-Gram-negative-bacteria/450 http://www.basilea.com/News-and-Media/Basileas-novel-oncology-drug-candidate-BAL101553-data-presented-at-international-conference-demonstrate-dual-mode-of-action/447 Tue, 06 Nov 2012 07:15:00 +0100 http://www.basilea.com/News-and-Media/Basileas-novel-oncology-drug-candidate-BAL101553-data-presented-at-international-conference-demonstrate-dual-mode-of-action/447 http://www.basilea.com/News-and-Media/Basileas-European-Marketing-Authorization-Application-for-ceftobiprole-for-the-treatment-of-pneumonia-accepted-for-review/445 Fri, 05 Oct 2012 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basileas-European-Marketing-Authorization-Application-for-ceftobiprole-for-the-treatment-of-pneumonia-accepted-for-review/445